Abstract: Preparation of antiarrhythmic (-)-.alpha.-{2-[bis(1-methylethyl)amino]ethyl}-.alpha.-phenyl-2-pyridineac etamide and pharmacologically acceptable salts thereof characterized by advantageously diminished and/or favorably altered side-effects such as anticholinergic activity is disclosed.
Abstract: 25-Alkylcholest-5-ene-3.beta.,22-diols and esters thereof adapted to inhibit the activity of 3-hydroxy-3-methylglutaryl coenzyme A reductase are disclosed.
Abstract: 25-Alkyl-3.beta.-hydroxycholest-5-en-7-ones and esters thereof adapted to lower serum cholesterol and inhibit the activity of 3-hydroxy-3-methylglutaryl coenzyme A reductase are disclosed.
Abstract: Preparation of alkyl 7-[tetrahydro-4-(3-hydroxy-1-octenyl)-2,6-dioxo-4H-cyclopenta-1,3-dioxol-5 -yl]-5-heptenoates adapted to counteract conception and suppress the activity of 3-methylglutaryl coenzyme A reductase is disclosed.
Abstract: A process for preparing 17-hydroxy-3-oxo-17.alpha.-pregna-4,6-diene-21-carboxylic acid .gamma.-lactone by contacting 17-hydroxy-3-oxy-17.alpha.-pregna-3,5-diene-21-carboxylic acid .gamma.-lactone with an appropriate halogenating agent in the presence of an amine base, the corresponding hydrohalide salt thereof, and approximately 1-2 molar equivalents (relative to the lactonic starting material) of water, using a cold solvent as the contact medium, and heating the resultant mixture with a dehydrohalogenating agent, is disclosed.
Abstract: Preparation and the antimicrobial and antihypercholesterolemic utility of 20/22/23/24-oxa-7-oxocholesterols and esters thereof are disclosed.
Abstract: Preparation of 21-(acetyloxy)-3-oxo-24-norchola-4,20(22)-diene-23-nitrile; its diuretic, antiulcerogenic, and antiviral utility; and intermediates whereby the preparation can be variously effected are disclosed.
Abstract: Preparation of 3.beta.,17-dihydroxy-5.alpha.,17.alpha.-pregn-20-ene-21-carboxylic acid .gamma.-lactone and esters thereof, the analgesic utility of the esters, and the utility of the diol both as an intermediate and by reason of its antiviral activity are disclosed.
Abstract: Preparation and the diuretic utility of 11.beta.,18-epoxy-9.alpha.-halo-17,18-dihydroxy-3-oxo-17.alpha.-pregn-4-en e-21-carboxylic acid .gamma.-lactones and congeners are disclosed.
Abstract: Various preparations and the diuretic activity of 7.xi.-(alkoxycarbonyl)-6.xi.-alkyl/halo-17-hydroxy-3-oxo-17.alpha.-pregn-4 -ene-21-carboxylic acid .gamma.-lactones and corresponding 21-carboxylic acids, their salts, and esters are disclosed.
Abstract: Preparation and the valuable antispasmodic, antiarrhythmic, antidiarrheal, and antiviral properties of 2-{3-[4-azatricyclo(4.3.1.1.sup.3,8)undecan-4-yl]-1,1-diphenylpropyl}-5-me thyl-1,3,4-oxadiazole and congeners are disclosed.
Abstract: Preparation of antiarrhythmic and antifungal (8.alpha.,13a.beta. )-8-carbocyclic/carbocyclic methyl-5,8,13,13a-tetrahydro-2,3,10,11-tetramethoxy-6H-dibenzo[a,g]quinoli zines is disclosed.
Abstract: The above-captioned compounds are produced from optionally substituted benzoin compounds by sequential reactions with trizincbismethylene dibromide, phosphorous trichloride and an appropriately substituted amine. The instant compounds are valuable as pharmacological agents as is evidenced by their anti-microbial, anti-arrhythmic, pepsin-inhibitory and anti-hypertensive activity.
Abstract: Preparation of antifungal [8.alpha.(E),13a.beta.]-5,8,13,13a-tetrahydro-2,3,10,11-tetramethoxy-8-(2- phenylethenyl)-6H-dibenzo[a,g]quinolizines is disclosed.